Recent News

• 11.06.2026 - How is sustainability shifting from a reporting exercise to a design constraint in manufacturing and development?
• 11.05.2026 - ICON Launches FIRECREST AI-Directed Video Engine, Changing the Economics of Site Communications
• 11.05.2026 - ICON launches FIRECREST AI-directed video engine
• 11.05.2026 - Refining biomarker-based patient selection for ADC trials
• 10.28.2026 - Q3 2026 Earnings Conference Call & Webcast
• 10.27.2026 - ICON Reports Third Quarter 2026 Results
• 10.27.2026 - ICON reports third quarter 2026 results
• 10.22.2026 - The adherence imperative: Clinical operations and patient centricity
• 10.15.2026 - Managing post-marketing pharmacovigilance across global markets
• 10.14.2026 - What’s holding back the gonorrhoea vaccine for women?

Recent Filings

• 11.05.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.04.2026 - 4 Statement of changes in beneficial ownership of securities
• 11.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 11.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 11.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 11.02.2026 - 144 Report of proposed sale of securities
• 11.02.2026 - 144 Report of proposed sale of securities
• 11.02.2026 - 144 Report of proposed sale of securities
• 10.27.2026 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 10.27.2026 - EX-99.1 EX-99.1